CytomX Therapeutics, Inc.

Q4 2020 13F Holders

Symbol
CTMX
CUSIP
23284F105
Type
Equity
Class
COM
Num filers
129
Total reported value, excl. options
$249M
Manager Report Date Value ($000) Shares